A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan CKD-828) Versus S-Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by S-Amlodipine Monotherapy.

Trial Profile

A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan CKD-828) Versus S-Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by S-Amlodipine Monotherapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Nov 2012

At a glance

  • Drugs Levamlodipine/telmisartan (Primary) ; Levamlodipine
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Sep 2012 Status changed from recruiting to completed as reported by Korean Clinical Trials Register record.
    • 15 Feb 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000321).
    • 04 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top